Cerecor, which is developing a novel adjunct therapy for major depressive disorder, filed on Friday with the SEC to raise up to $32 million in an initial public offering.
The Baltimore, MD-based company, which was founded in 2011, plans to list on the NASDAQ under the symbol CERC. Cerecor initially filed confidentially on December 20, 2013. Maxim Group LLC is the sole bookrunner on the deal. No pricing terms were disclosed.
